AFT Pharmaceuticals Limited

NZSE:AFT Stock Report

Mkt Cap: NZ$390.1m

We’ve recently updated our valuation analysis.

AFT Pharmaceuticals Valuation

Is AFT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AFT?

Other financial metrics that can be useful for relative valuation.

AFT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3x
Enterprise Value/EBITDA22.1x
PEG Ratio0.9x

Price to Earnings Ratio vs Peers

How does AFT's PE Ratio compare to its peers?

The above table shows the PE ratio for AFT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average9.8x
524558 Neuland Laboratories
22.4x11.1%₹18.6b
2348 Dawnrays Pharmaceutical (Holdings)
4.8xn/aHK$2.0b
A003220 Daewon Pharmaceutical
10.1x9.1%₩350.8b
BTMD biote
2.2x-13.0%US$231.8m
AFT AFT Pharmaceuticals
22.9x25.4%NZ$390.1m

Price-To-Earnings vs Peers: AFT is expensive based on its Price-To-Earnings Ratio (22.9x) compared to the peer average (9.8x).


Price to Earnings Ratio vs Industry

How does AFT's PE Ratio compare vs other companies in the Global Pharmaceuticals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a55.1%
n/an/an/a

Price-To-Earnings vs Industry: AFT is expensive based on its Price-To-Earnings Ratio (22.9x) compared to the Global Pharmaceuticals industry average (21.7x)


Price to Earnings Ratio vs Fair Ratio

What is AFT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AFT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio22.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AFT's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of AFT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AFT (NZ$3.72) is trading above our estimate of fair value (NZ$2.29)

Significantly Below Fair Value: AFT is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AFT forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentNZ$3.72
NZ$3.89
+4.5%
16.3%NZ$4.70NZ$3.16n/a3
Jan ’24NZ$3.65
NZ$5.23
+43.3%
35.7%NZ$8.26NZ$3.16n/a4
Dec ’23NZ$3.77
NZ$5.23
+38.7%
35.7%NZ$8.26NZ$3.16n/a4
Nov ’23NZ$3.72
NZ$5.51
+48.2%
29.5%NZ$8.26NZ$4.00n/a4
Oct ’23NZ$3.30
NZ$5.69
+72.3%
32.5%NZ$8.26NZ$4.00n/a3
Sep ’23NZ$3.45
NZ$5.69
+64.8%
32.5%NZ$8.26NZ$4.00n/a3
Aug ’23NZ$3.62
NZ$5.69
+57.0%
32.5%NZ$8.26NZ$4.00n/a3
Jul ’23NZ$3.61
NZ$5.69
+57.5%
32.5%NZ$8.26NZ$4.00n/a3
Jun ’23NZ$4.25
NZ$5.95
+40.0%
27.4%NZ$8.26NZ$4.80n/a3
May ’23NZ$3.60
NZ$5.88
+63.3%
21.9%NZ$7.69NZ$4.80n/a3
Apr ’23NZ$3.61
NZ$5.88
+62.9%
21.9%NZ$7.69NZ$4.80n/a3
Mar ’23NZ$4.00
NZ$5.88
+47.0%
21.9%NZ$7.69NZ$4.80n/a3
Feb ’23NZ$4.25
NZ$5.88
+38.4%
21.9%NZ$7.69NZ$4.80n/a3
Jan ’23NZ$4.48
NZ$5.88
+31.2%
21.9%NZ$7.69NZ$4.80NZ$3.653
Dec ’22NZ$4.45
NZ$5.88
+32.1%
21.9%NZ$7.69NZ$4.80NZ$3.773
Nov ’22NZ$4.40
NZ$4.85
+10.2%
3.1%NZ$5.00NZ$4.70NZ$3.722
Oct ’22NZ$4.20
NZ$4.85
+15.5%
3.1%NZ$5.00NZ$4.70NZ$3.302
Sep ’22NZ$4.22
NZ$4.85
+14.9%
3.1%NZ$5.00NZ$4.70NZ$3.452
Aug ’22NZ$4.55
NZ$4.85
+6.6%
3.1%NZ$5.00NZ$4.70NZ$3.622
Jul ’22NZ$4.65
NZ$4.85
+4.3%
3.1%NZ$5.00NZ$4.70NZ$3.612
Jun ’22NZ$4.75
NZ$4.85
+2.1%
3.1%NZ$5.00NZ$4.70NZ$4.252
May ’22NZ$4.67
NZ$4.61
-1.4%
6.4%NZ$4.90NZ$4.31NZ$3.602
Apr ’22NZ$4.38
NZ$4.95
+13.0%
1.0%NZ$5.00NZ$4.90NZ$3.612
Mar ’22NZ$4.17
NZ$5.75
+37.9%
13.0%NZ$6.50NZ$5.00NZ$4.002
Feb ’22NZ$5.01
NZ$5.75
+14.8%
13.0%NZ$6.50NZ$5.00NZ$4.252
Jan ’22NZ$5.51
NZ$5.75
+4.4%
13.0%NZ$6.50NZ$5.00NZ$4.482

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies